Valved Graft PMCF Study

NCT ID: NCT04754217

Last Updated: 2025-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

260 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-13

Study Completion Date

2029-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Disease Ascending Aorta Abnormality Aortic Dissection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

VAVGJ

VAVGJ

Intervention Type DEVICE

Replacement of the aortic valve and ascending aorta

Group 2

CAVGJ

CAVGJ

Intervention Type DEVICE

Replacement of the aortic valve and ascending aorta

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VAVGJ

Replacement of the aortic valve and ascending aorta

Intervention Type DEVICE

CAVGJ

Replacement of the aortic valve and ascending aorta

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement

Exclusion Criteria

* anticoagulation therapy intolerant
* active endocarditis
* anatomical or medical, surgical, psychological or social contraindications
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital - Univ. of Alabama at Birmingham (UAB)

Birmingham, Alabama, United States

Site Status WITHDRAWN

University of Michigan

Ann Arbor, Michigan, United States

Site Status RECRUITING

Mission Health & Hospitals

Asheville, North Carolina, United States

Site Status WITHDRAWN

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status RECRUITING

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status RECRUITING

Klinik Floridsdorf

Vienna, , Austria

Site Status RECRUITING

Rigshospitalet

Copenhagen, , Denmark

Site Status RECRUITING

CHU de Besancon - Jean Minjoz

Besançon, , France

Site Status RECRUITING

CHRU Lille

Lille, , France

Site Status RECRUITING

Groupe Hospitalier Bichat - Claude Bernard

Paris, , France

Site Status RECRUITING

Herz-und Diabetes Zentrum NRW

Bad Oeynhausen, , Germany

Site Status RECRUITING

Deutsches Herzzentrum Berlin

Berlin, , Germany

Site Status RECRUITING

Klinikum Links der Weser

Bremen, , Germany

Site Status RECRUITING

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status RECRUITING

Onassis Cardiac Surgery Center

Athens, , Greece

Site Status RECRUITING

Policlinico S.Orsola-Malpighi

Bologna, , Italy

Site Status RECRUITING

Ospedale San Raffaele

Milan, , Italy

Site Status RECRUITING

Policlinico San Donato

San Donato Milanese, , Italy

Site Status RECRUITING

Wojewodzki Szpital Zespolony w Kielcach

Kielce, , Poland

Site Status WITHDRAWN

Krakowski Szpital Specjalistyczny im. Jana Pawla II

Krakow, , Poland

Site Status RECRUITING

Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi

Lodz, , Poland

Site Status ACTIVE_NOT_RECRUITING

The Cardinal Stefan Wyszynski Institute of Cardiology

Warsaw, , Poland

Site Status RECRUITING

Hospital Universitario del Vinalopó

Elche, , Spain

Site Status RECRUITING

Hospital Universitario Son Espases

Palma de Mallorca, , Spain

Site Status RECRUITING

James Cook University Hospital

Middlesbrough, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Denmark France Germany Greece Italy Poland Spain United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paolo Amato

Role: CONTACT

+39 335 61 40 573

Karine Miquel

Role: CONTACT

+32 479 60 01 07

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ABT-CIP-10386

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.